
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Treovir & Matica Bio Partner on Pediatric Brain Tumor Therapies Development
Details : The collaboration aims to advance G207 HSV-based oncolytic therapy for pediatric patients with brain and other neurological cancers.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
December 04, 2024

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Details : G207 is a Other Large Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 23, 2020

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Details : G207 is a Other Large Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Brain Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 11, 2019

Contact Us!